The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
alphatec stock sees price target increase amid strong institutional interest
Alphatec Holdings, Inc., a medical technology company specializing in spinal disorder treatments, has seen its stock price target raised to $21.00 by Barclays, indicating a potential upside of 80.88%. The company currently holds a "Moderate Buy" rating from analysts, with a consensus price target of $17.56. Institutional investors own 66.35% of the stock, while insiders hold 22.80%.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.